HopeStage
Back to all studies
CompletedNCT00466791

Methylphenidate patch for children with ADHD

About this titleRead the official source — NCT00466791

This study evaluated the safety of Methylphenidate Transdermal System for people with ADHD.

Medication studyAges 6–12United States
The study in practice

Understand this study

What did researchers investigate?

This study evaluated the safety of Methylphenidate Transdermal System for people with ADHD.

Who was this study for?

Listed age limits: 6 years to 12 years.

Listed locations
IrvineSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 2004
Recruitment status
Completed
Enrollment listed in the registry
93
Sponsor
Noven Therapeutics
Sponsor type
Biotech company
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 6 Years to 12 Years
Official registry ID
NCT00466791
Official title
Show the full official title

A Phase II, Randomized, Double-blind, Multi-center, Placebo-controlled, Dose Optimization, Analog Classroom, Crossover Study Designed to Assess the Time Course of Treatment Effect, Tolerability and Safety of Methylphenidate Transdermal System (MTS) in Pediatric Patients Aged 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Irvine

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

This study evaluated the safety of Methylphenidate Transdermal System for people with ADHD.

Who is behind this study?

The study sponsor is Noven Therapeutics.

Did this study involve medication?

Yes. The study involved medication, including Methylphenidate Transdermal System.

Who was this study for?

Listed age limits: 6 years to 12 years.

Want to explore more studies?

Explore studies